BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24660726)

  • 1. Comparison of breast cancers diagnosed in screening patients in their 40s with and without family history of breast cancer in a community outpatient facility.
    Destounis SV; Arieno AL; Morgan RC; Cavanaugh D; Seifert PJ; Murphy PF; Somerville PA
    AJR Am J Roentgenol; 2014 Apr; 202(4):928-32. PubMed ID: 24660726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Impact of Risk-Based Screening Mammography in Women 40-49 Years Old.
    Price ER; Keedy AW; Gidwaney R; Sickles EA; Joe BN
    AJR Am J Roentgenol; 2015 Dec; 205(6):1360-4. PubMed ID: 26204111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.
    Barth RJ; Gibson GR; Carney PA; Mott LA; Becher RD; Poplack SP
    AJR Am J Roentgenol; 2005 Jan; 184(1):324-9. PubMed ID: 15615996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
    Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
    Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening mammography for women in their 40s: a retrospective study of the potential impact of the U.S. Preventive Service Task Force's 2009 breast cancer screening recommendations.
    Arleo EK; Dashevsky BZ; Reichman M; Babagbemi K; Drotman M; Rosenblatt R
    AJR Am J Roentgenol; 2013 Dec; 201(6):1401-6. PubMed ID: 24261383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcifications in digital mammographic screening: improvement of early detection of invasive breast cancers?
    Weigel S; Decker T; Korsching E; Hungermann D; Böcker W; Heindel W
    Radiology; 2010 Jun; 255(3):738-45. PubMed ID: 20501713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.
    Saadatmand S; Vos JR; Hooning MJ; Oosterwijk JC; Koppert LB; de Bock GH; Ausems MG; van Asperen CJ; Aalfs CM; Gómez Garcia EB; Meijers-Heijboer H; Hoogerbrugge N; Piek M; Seynaeve C; Verhoef C; Rookus M; Tilanus-Linthorst MM;
    Int J Cancer; 2014 Dec; 135(12):2940-9. PubMed ID: 24789418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Mammography for Women in Their 40s: The Potential Impact of the American Cancer Society and U.S. Preventive Services Task Force Breast Cancer Screening Recommendations.
    Pitman JA; McGinty GB; Soman RR; Drotman MB; Reichman MB; Arleo EK
    AJR Am J Roentgenol; 2017 Sep; 209(3):697-702. PubMed ID: 28504572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection and diagnosis of early, occult and minimal breast cancer.
    Hickey RC; Gallager HS; Dodd GD; Samuels BI; Paulus DD; Moore DL
    Adv Surg; 1976; 10():287-312. PubMed ID: 185891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual screening mammography for breast cancer in women 75 years old or older: to screen or not to screen.
    Hartman M; Drotman M; Arleo EK
    AJR Am J Roentgenol; 2015 May; 204(5):1132-6. PubMed ID: 25905953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study.
    Setz-Pels W; Duijm LE; Groenewoud JH; Louwman MW; Jansen FH; van Beek M; Plaisier ML; Voogd AC
    Breast Cancer Res Treat; 2011 Oct; 129(3):955-61. PubMed ID: 21553118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower sensitivity of screening mammography after previous benign breast surgery.
    van Breest Smallenburg V; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; van Beek M; Louwman MW
    Int J Cancer; 2012 Jan; 130(1):122-8. PubMed ID: 21328339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia.
    Randall D; Morrell S; Taylor R; Hung WT
    Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis?
    Kremer ME; Downs-Holmes C; Novak RD; Lyons JA; Silverman P; Pham RM; Plecha DM
    AJR Am J Roentgenol; 2012 May; 198(5):1218-22. PubMed ID: 22528917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast MR imaging screening in women with a history of breast conservation therapy.
    Gweon HM; Cho N; Han W; Yi A; Moon HG; Noh DY; Moon WK
    Radiology; 2014 Aug; 272(2):366-73. PubMed ID: 24635678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.